Regardless, CBX2/7 expression status informs about the metabolic phenotype of breast tumors, patient outcome, and sensitivity to anticancer drugs with potential implications in current or future strategies targeting clinical breast cancer. The gene discussed is CBX2; the disease is breast neoplasm.